日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An adapted consensus protein design strategy for identifying globally optimal biotherapeutics

一种用于识别全局最优生物治疗药物的改进型共识蛋白设计策略

Yanyun Liu ,Kenny Tsang ,Michelle Mays ,Gale Hansen ,Jeffrey Chiecko ,Maureen Crames ,Yangjie Wei ,Weijie Zhou ,Chase Fredrick ,James Hu ,Dongmei Liu ,Douglas Gebhard ,Zhong-Fu Huang ,Akshita Datar ,Anthony Kronkaitis ,Kristina Gueneva-Boucheva ,Daniel Seeliger ,Fei Han ,Saurabh Sen ,Srinath Kasturirangan ,Justin M Scheer ,Andrew E Nixon ,Tadas Panavas ,Michael S Marlow ,Sandeep Kumar

Prediction and Reduction of the Aggregation of Monoclonal Antibodies

单克隆抗体聚集的预测和减少

Rob van der Kant, Anne R Karow-Zwick, Joost Van Durme, Michaela Blech, Rodrigo Gallardo, Daniel Seeliger, Kerstin Aßfalg, Pieter Baatsen, Griet Compernolle, Ann Gils, Joey M Studts, Patrick Schulz, Patrick Garidel, Joost Schymkowitz, Frederic Rousseau

Structure-guided residence time optimization of a dabigatran reversal agent

达比加群逆转剂的结构指导停留时间优化

Felix Schiele, Joanne van Ryn, Tobias Litzenburger, Michael Ritter, Daniel Seeliger, Herbert Nar

Boosting antibody developability through rational sequence optimization

通过合理的序列优化提高抗体的可开发性

Daniel Seeliger, Patrick Schulz, Tobias Litzenburger, Julia Spitz, Stefan Hoerer, Michaela Blech, Barbara Enenkel, Joey M Studts, Patrick Garidel, Anne R Karow

Discovery of novel human aquaporin-1 blockers

发现新型人类水通道蛋白-1阻断剂

Daniel Seeliger, Cinta Zapater, Dawid Krenc, Rose Haddoub, Sabine Flitsch, Eric Beitz, Joan Cerdà, Bert L de Groot